| Use of Low Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitors (PCSK9i) Initiation |
| Author(s): Rymer JA, Mues KE, Monda KL, Bratton EW, Wirtz HS, Okerson T, Overman RA, Brookhart MA, Muntner P, Wang TY |
| Affiliations(s): From the Duke Clinical Research InstituteDurham NC (J.A.R., T.Y.W.); Center for Observational ResearchAmgen IncThousand Oaks CA (K.E.M., K.L.M., H.S.W., T.O.); IQVIA, Realâ€World Evidence SolutionsDurham NC (E.W.B.); NoviSci, IncDurham NC (R.A.O., M.A.B.); University of North Carolina at Chapel HillChapel Hill NC (M.A.B.); Department of EpidemiologyUniversity of Alabama at BirminghamAL (P.M.). |
Publication(s): Originally published24 Apr 2020https://doi.org/10.1161/JAHA.119.014347Journal of the American Heart Association. ;0:e014347
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Cardiovascular disease, Medication compliance,
2020 |
|
L:
A: |
English
Epidemiological study, |
|
 |
| |
| |
| High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study |
| Author(s): Gerard E.Franciscoa; Daniel S.Bandari; Ganesh Bavikattec; Wolfgang H.Jost; Emily McCusker; Joan Largent; Alekse Zuzek; Alberto Esquenazi |
| Affiliations(s): a
The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA
b
Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA
c
The Walton Centre, Liverpool, UK
d
University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany
e
Parkinson-Klinik Ortenau, Wolfach, Germany
f
Allergan, an AbbVie Company, Irvine, CA, USA
g
IQVIA Real-World Evidence Solutions, Cambridge, MA, USA
h
MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA |
Publication(s): PM R
. 2020 Jan 17. doi: 10.1002/pmrj.12328.
PMID: 31953896 DOI: 10.1002/pmrj.12328
|
| Document Type(s): Article, |
| Countries: Asia Pacific, Europe, USA, |
| Click here for the abstract |
C:
Y: |
Drug Utlization Study, Medication compliance,
2020 |
|
L:
A: |
English
Methodology, Observational study, |
|
|
| |
| |
| Persistence with Selective Serotonin (Norepinephrine) Reuptake Inhibitor Therapy in
Germany |
| Author(s): Kostev K, Kap EJ |
| Affiliations(s): IQVIA, Frankfurt am Main, Germany |
| Publication(s): |
| Document Type(s): Abstract, |
| Countries: Germany, |
C:
Y: |
Medication compliance, Mental health,
2018 |
|
L:
A: |
English
Database Study, Epidemiological study, |
|
|
| |
| |
| The Impact of Risk Minimization Measures on Compliance and Prescribing Practices of Flupirtine in Germany. |
| Author(s): Kaplan S, Ehlken B, Hamann X |
| Affiliations(s): Teva Pharmaceutical Industries Ltd , Petach Tikva , Israel.
IQVIA (formerly IMS Health) , Munich , Germany.
Ratiopharm GmbH (an affiliate of Teva Pharmaceuticals Europe BV) , Ulm , Germany
|
Publication(s): Curr Med Res Opin
|
| Document Type(s): Article, |
| Countries: Germany, |
C:
Y: |
Drug Utlization Study, Medication compliance,
2018 |
|
L:
A: |
English
Retrospective cohort analysis, |
|
|
| |
| |
| L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions |
| Author(s): Catherine Collet(1) – Anne de Saunière (1) – Dominique Perrot (2) – Isabelle Bardoulat (2) |
| Affiliations(s): (1) ARS Ile de France, Paris, France – (2) Quintiles IMS, Paris, France |
Publication(s): Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France
|
| Document Type(s): Poster, |
| Countries: France, |
C:
Y: |
Diabetes, Medication compliance,
2017 |
|
L:
A: |
French
Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis, |
|
|
| |
| |
| Impact of A Pharmacist Medication Adherence Consultation Program on Health Care Costs and Risk of Hospitalization |
| Author(s): Wade R.L.1, Hill J.W.1, Akinbosoye O.2, Jiang Z.2, Mu Y.2, Sun K.1, Karkare S3, Taitel M.S.2 |
| Affiliations(s): 1IMS Health, Plymouth Meeting, PA, USA, 2Walgreen Co., Deerfield, IL, USA, 3IMS Health,Deerfield, IL, USA |
Publication(s): VALUE IN HEALTH. 2015. 18(3):A3
|
| Document Type(s): Podium presentation, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Medication compliance,
2017 |
|
L:
A: |
English
Retrospective database analysis, Survey research, |
|
|
| |
| |
| L’observance médicamenteuse des patients diabétiques de type 2 en île-de-france : état des lieux et priorités d’actions [Drug adherence in patients with type 2 diabetes in Île-de-France: state of play and priorities for action]. |
| Author(s): Bardoulat I1, Chauvin F1, De Saunière A2, Le Jeunne P1, Perrot D1, Collet C2 |
| Affiliations(s): 1 QuintilesIMS, La Défense, France 2 ARS Île-de-France, Paris, France |
Publication(s): 9ème Colloque données de santé en vie réelle / AFCROs (Cité Universitaire, Paris, 13 juin 2017)
|
| Document Type(s): Oral presentation, |
| Countries: France, |
C:
Y: |
Diabetes, Medication compliance,
2017 |
|
L:
A: |
French
Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis, |
|
|
| |
| |
| L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions [Drug adherence in patients with type II diabetes in the Île-de-France region: study results and priorities for action]. |
| Author(s): Collet C1, De Saunière A1, Perrot D2, Bardoulat I2 |
| Affiliations(s): 1 ARS Ile de France, Paris, France 2 Quintiles IMS, Paris, France |
Publication(s): Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France
|
| Document Type(s): Poster, |
| Countries: France, |
C:
Y: |
Diabetes, Medication compliance,
2017 |
|
L:
A: |
French
Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis, |
|
|
| |
| |
| METHODOLOGICAL REVIEW OF SURVIVAL MODELS: APPLICATION TO A PERSISTENCE ANALYSIS BASED ON LONG ACTING PARENTERAL ANTIPSYCHOTIC IN RETAIL PHARMACIES IN FRANCE |
| Author(s): Harmand S, El Mouaddin N |
| Affiliations(s): IMS Health France |
Publication(s): 19th ISPOR COngress 2016
|
| Document Type(s): Abstract, Poster, |
| Countries: France, |
C:
Y: |
Medication compliance, Methodology,
2016 |
|
L:
A: |
English
Compliance, Database Study, Methodology, |
|
|
| |
| |
| Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Dermatology Results from the COMPANION Study |
| Author(s): Shear N1,2, Bessette L3, Marshall JK4, Lebovic G5,6, Gerega S7, Millson B7, Gaetano T8, Gazel S8, Latour M8, Laliberté MC8 |
| Affiliations(s): 1 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 2 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada; 4Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 7 IMS Brogan, Kirkland, Quebec, Canada 8 AbbVie Corporation, St. Laurent, Quebec, Canada |
Publication(s): Dermatology Update 2016 Annual Meeting, November 3-6, Montreal, Canada
|
| Document Type(s): Poster, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Dermatology, Medication compliance,
2016 |
|
L:
A: |
English
Database Study, |
|
|
| |
| |
 1 of 5 
|
